Dergiler / BEYOGLU EYE JOURNAL / 2020 / Cilt: 5 - Sayı: 2

Effects of Topical Nepafenac and Fluorometholone on Macular Thickness After Posterior Capsulotomy Using Neodymium-doped Yttrium-Aluminum-Garnet Laser

Sayfa
64–72
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The 2 drugs were comparable; neither demonstrated apparent superiority to the other.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of this study was to assess the effects of topical 0.1% nepafenac and 0.1% fluorometholone on macular thickness (MT) after a neodymium: yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy and to compare the findings with those of untreated patients.
📊
Temel Bulgular & Veri:Methods: This prospective study included 75 eyes of 75 patients with posterior capsule opacification.
💡
Sonuç & Katkı:The 2 drugs were comparable; neither demonstrated apparent superiority to the other.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of this study was to assess the effects of topical 0.1% nepafenac and 0.1% fluorometholone on macular thickness (MT) after a neodymium: yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy and to compare the findings with those of untreated patients. Methods: This prospective study included 75 eyes of 75 patients with posterior capsule opacification. The patients were divided into 3 groups according to the medications administered after a capsulotomy procedure. Group 1 comprised 25 patients who were prescribed 0.1% nepafenac for a week, Group 2 consisted of 25 patients who were prescribed 0.1% fluorometholone for a week, and Group 3 consisted of 25 patients who were not prescribed any medication. A circularshaped capsulotomy was performed in all cases. MT was measured before the capsulotomy and at the first day, first week, and first month after the procedure using spectral domain-optical coherence tomography and the change values were compared within and between groups. Results: In Group 1, the superior and nasal parafoveal MT, temporal, and nasal perifoveal MT values at the first month were statistically significantly greater than those observed in the first week (p<0.05 for all values). In Group 2, the superior and nasal parafoveal MT and inferior perifoveal MT measurements in the first month were greater than those recorded the first week (p<0.05 for all values). In Group 3, there was a gradual increase seen in the first day, first week, and first month in the superior and temporal parafoveal MT value (p<0.05 for all). The change value in the parafoveal temporal quadrant was significant between groups, indicating a greater increase in the untreated group compared with the nepafenac and fluorometholone groups (p=0.04). Conclusion: An increase in MT can occur after an Nd:YAG laser posterior capsulotomy. Both topical 0.1% nepafenac and 0.1% fluorometholone can prevent this increase. The 2 drugs were comparable; neither demonstrated apparent superiority to the other.

🔖

Bu Makaleye Atıf Yap

ATİLGAN, C. U., KOSEKAHYA, P., YETKİN, E., CAGLAYAN, M., GOKER, Y. S., SENDUL, S. Y. (2020). Effects of Topical Nepafenac and Fluorometholone on Macular Thickness After Posterior Capsulotomy Using Neodymium-doped Yttrium-Aluminum-Garnet Laser. BEYOGLU EYE JOURNAL, Cilt: 5 - Sayı: 2, 64–72. https://ajindex.com/articles/142050

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Frezotti R, Caporossi A. Pathogenesis of posterior capsule opacification. Part I. Epidemiological and clinical statistical data. J Cataract Refract Surg 1990;16:347–52
  2. Buehl W, Sacu S, Findl O. Association between intensity of posterior capsule opacification and contrast sensitivity. Am J Ophthalmol 2005;140:927–30
  3. Raj SM, Vasavada AR, Johar SRK, Vasavada VA, Vasavada VA. Post-operative capsular opacification: a review. Int J Biomed Sci Master Publ Group 2007;3:237–50
  4. Hayashi K, Hayashi H, Nakado F, Hayashi F. Correlation between posterior capsule opacification and visual function before and after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol 2003;136:720–6
  5. Aslam TM, Devlin H, Dhillon B. Use of Nd:Yag Laser Capsulotomy. Survey Ophthalmol 2003:48:594–612
  6. Billotte C, Berdeaux G. Adverse clinical consequences of neodymium:YAG laser treatment of posterior capsule opacification. J Cataract Refract Surg 2004;30:2064–71
  7. Karahan E, Er D, Kaynak S. An Overview of Nd:YAG Laser Capsulotomy. Med Hypothesis Discov Innov Ophthalmol 2014;3:45–50
  8. Ranta P, Tommila P, Kivela T. Retinal breaks and detachment after neodymium: YAG laser posterior capsulotomy: five-year incidence in a prospective cohort. J Cataract Refract Surg 2004;30:58–66
  9. Altamirano D, Mermoud A, Pittet N, Van Melle G, Herbort CP. Aqueous humor analysis after Nd:Yag laser capsulotomy with the laser flare-cell meter. J Cataract Refract Surg 1992;1:554–8
  10. Gore VS. The study of complications of Nd:YAG laser capsulotomy. Int J Bioinformative Res 2012:4:265–8
  11. Wielders LHP, Schouten JSAG, Winkens B, van den Biggelaar FJHM, Veldhuizen CA, Findl O, et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg 2018;44:429–39
  12. Chun AG. Comparison of Incidence of Cystoid Macular Edema Following Nd: YAG Capsulotomy In Postoperative Treatment With Topical Steroids Versus Non-steroidal Anti-inflammatory Drugs. IOVS 2011;524516
  13. Karahan E, Tuncer I, Zengin MO. The Effect of ND:YAG Laser Posterior Capsulotomy Size on Refraction, Intraocular Pressure Macular Thickness. J Ophthalmol 2014;2014:846385
  14. Ari S, Cingü AK, Sahin A, Çinar Y, Çaça I. The effects of Nd:YAG laser posterior capsulotomy on macular thickness, intraocular pressure, and visual acuity. Ophthalmic Surg Lasers Imaging 2012;43:395–400
  15. Jinagal J, Sahu S, Gupta G, Khurana S, Gupta R, Gupta P